A Randomized, Placebo-Controlled, Double-Blind, Parallel Study of the Anti-Hypertensive Efficacy and Safety of Losartan Monotherapy as Compared to HCTZ Monotherapy and to the Combination of Losartan and HCTZ in Japanese Patients With Essential Hypertension.
Latest Information Update: 05 May 2022
At a glance
- Drugs Losartan (Primary) ; Hydrochlorothiazide; Losartan/hydrochlorothiazide
- Indications Essential hypertension
- Focus Therapeutic Use
- Sponsors Organon
- 02 Jan 2008 Status changed from in progress to completed.
- 18 Nov 2005 New trial record.